FAP-1 association with Fas (Apo-1) inhibits fas expression on the cell surface

Molecular and Cellular Biology

Volumn 23, Issue 10, 2003, Pages 3623-3635

  Ivanov, Vladimir N ^a   Bergami, Pablo Lopez ^a   Maulit, Gabriel ^a   Sato, Taka Aki ^b   Sassoon, David ^a   Ronai, Ze'ev ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN; PROTEIN FAP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CYTOSKELETON; EMBRYO; FIBROBLAST; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CARRIER PROTEINS; CELL DEATH; CELL MEMBRANE; CELL SEPARATION; FIBROBLASTS; FLOW CYTOMETRY; GENES, DOMINANT; GOLGI APPARATUS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUMINESCENT PROTEINS; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MUTATION; PHOSPHORYLATION; PLASMIDS; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE-PHOSPHATASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA;

EID: 0038302839     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.10.3623-3635.2003     Document Type: Article

References (47)

1. Aaronson, S. A., and G. J. Todaro. 1968. Development of 3T3-like lines from Balb/c mouse embryo cultures: transformation susceptibility to SV40. J. Cell. Physiol. 72:141-148.
2. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294-300.
3. Aragane, Y., A. Maeda, C. Y. Cui, T. Tezuka, Y. Kaneda, and T. Schwarz. 2000. Inhibition of growth of melanoma cells by CD95 (Fas/APO-1) gene transfer in vivo. J. Investig. Dermatol. 115:1008-1014.
4. Arai, M., M. Kannagi, M. Matsuoka, T. Sato, N. Yamamoto, and M. Fuji. 1998. Expression of Fap-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type-1 associated myelopath/tropical spastic paraparesis patients. AIDS Res. Hum. Retrovir. 14:261-267.
5. fynT. J. Biol. Chem. 271:5968-5971.
6. Augstein, P., A. Dunger, C. Salzsieder, P. Heinke, R. Kubernath, J. Bahr, U. Fischer, R. Rettig, and E. Salzsieder. 2002. Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression. Biochem. Biophys. Res. Commun. 290:443-451.
7. Banville, D., S. Ahmad, R. Stocco, and S. H. Shen. 1994. A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases. J. Biol. Chem. 269:22320-22327.
8. Bennett, M., K. Macdonald, S. W. Chan, J. P. Luzio, R. Simaari, and P. Weissberg. 1998. Cell surface trafficking of Fas: a rapid mechanism of p53 mediated apoptosis. Science 9:290-293.
9. Blom, N., S. Gammeltoft, and S. Brunak. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1351-1362.
10. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
11. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2:243-247.
12. Dhawan, P., and A. Richmond. 2002. A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells. J. Biol. Chem. 8:7920-7928.
13. Elnemr, A., T. Ohta, A. Yachie, M. Kayahara, H. Kitagawa, T. Fujimura, I. Nimomiya, S. Fushida, G. I. Nishimura, K. Shimizu, and K. Miwa. 2001. Human pancreatic cancer cells disable function of Fas receptors at several levels in Fas signal transduction pathway. Int. J. Oncol. 18:311-316.
14. Elsing, A., and H. G. Burgert. 1998. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. USA 95:10072-10077.
15. Hug, H. 1997. Fas-mediated apoptosis in tumor formation and defense, Biol. Chem. 378:1405-1412.
16. Inoue, S., A. E. Salah-Eldin, and K. Omoteyama. 2001. Apoptosis and anticancer drug resistance. Hum. Cell 14:211-221.
17. NTR and their effect on NF-κB activation. FEBS Lett. 460:191-198.
18. Irie, S., Y. Li, H. Kanki, T. Ohyama, L. L. Deaven, S. Somlo, and T. A. Sato. 2001. Identification of two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells. DNA Seq. 11:519-526.
19. Ivanov, V. N., A. Bhoumik, M. Krasilnikov, R. Raz, L. B. Owen-Schaub, D. Levy, C. M. Horvath, and Z. Ronai. 2001. Cooperation between STAT3 and c-Jun suppresses Fas transcription. Mol. Cell 7:517-528.
20. Ivanov, V. N., and Z. Ronai. 1999. Down regulation of TNFα expression by ATF2 increases UVC-induced apoptosis of late stage melanoma cells. J. Biol. Chem. 274:14079-14089.
21. Ivanov, V. N., and Z. Ronai. 2000. p38 protects human melanoma cells from UV-induced apoptosis through down-regulation of NF-κB activity and Fas expression. Oncogene 19:3003-3012.
22. Ivanov, V. N., M. Krasilnnikov, and Z. Ronai. 2002. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J. Biol. Chem. 277:4932-4944.
23. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301-310.
24. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 12:789-795.
25. Landowski, T. H., N. Qu, I. Buyuksal, J. S. Painter, and W. S. Dalton. 1997. Mutations in the Fas antigen in patients with multiple myeloma. Blood 90:4266-4270.
26. Lee, S. H., M. S. Shin, H. S. Lee, J. H. Bae, H. K. Lee, H. S. Kim, S. Y. Kim, J. J. Jang, M. Joo, Y. K. Kang, W. S. Park, J. Y. Park, R. R. Oh, S. Y. Han, J. H. Lee, S. H. Kim, J. Y. Lee, and H. J. Yoo. 2001. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma. Hum. Pathol. 32:250-256.
27. Lee, S. H., M. S. Shin, W. S. Park, S. Y. Kim, H. S. Kim, J. H. Lee, S. Y. Han, H. K. Lee, J. Y. Park, R. R. Oh, J. J. Jang, J. Y. Lee, and N. J. Yoo. 1999. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues. APMIS 107:1101-1108.
28. Li, Y., H. Kanki, T. Hachiya, T. Ohyama, S. Irie, G. Tang, J. Mukai, and T. Sato. 1997. Negative regulation of Fas-mediated apoptosis by FAP-1 in human cancer cells. Int. J. Cancer 87:8539-8545.
29. Maekawa, K., N. Imagawa, M. Nagamatsu, and S. Harada. 1994. Molecular cloning of a novel-protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett. 337:200-206.
30. Meinhold-Heerlein, I., F. Stenner-Liewen, H. Liewen, S. Kitada, M. Krajewska, S. Krajewski, J. M. Zapata, A. Monks, D. A. Scudiero, T. Bauknecht, and J. C. Reed. 2001. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am. J. Pathol. 158:1335-1344.
31. Nagata, S. 1999. Fas-ligand-induced apoptosis. Annu. Rev. Genet. 33:29-55.
32. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow-cytometry. J. Immunol. Methods 139:271-279.
33. Owen-Schaub, L. B., K. L. van Golen, L. L. Hill, and J. E. Price. 1998. Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 188:1717-1723.
34. Saras, J., L. Claesson-Welsh, C. H. Heldin, and L. J. Gonez. 1994. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-associated proteins. J. Biol. Chem. 269:24082-24089.
35. Saras, J., U. Engstrom, L. J. Gonez, and C. H. Heldin. 1997. Characterization of the interaction between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas. J. Biol. Chem. 272:20979-20981.
36. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-415.
37. Sawa, E., M. Takahashi, M. Kamishohara, T. Tazunoki, K. Kimura, M. Arai, T. Miyazaki, S. Kataoka, and T. Nishitoba. 1999. Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding. J. Med. Chem. 42:3289-3299.
38. Sheng, M., and C. Sala. 2001. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 24:1-29.
39. Shin, M. S., W. S. Park, S. Y. Kim, H. S. Kim, S. J. Kang, K. Y. Song, J. Y. Park, S. M. Dong, J. H. Pi, R. R. Oh, J. Y. Lee, N. J. Yoo, and S. H. Lee. 1999. Alterations of Fas (Apo-1/CD95) gene in cutaneous malignant melanoma. Am. J. Pathol. 154:1785-1791.
40. Simon, H. U., S. Yousefi, B. Dibbert, H. Hebestreit, M. Weber, D. R. Branch, K. Blaser, F. Levi-Schaffer, and G. P. Anderson. 1998. Role for tyrosine phosphorylation and Lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils. Blood 92:547-557.
41. Sodeman, T., S. F. Bronk, P. J. Roberts, H. Miyoshi, and G. J. Gores. 2000. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am. J. Physiol. Gastrointest. Liver Physiol. 278:992-999.
42. Soubrane, C., R. Mouawad, E. C. Antoine, O. Verola, M. Gil-Delgado, and D. Khayat. 2000. A comparative study of Fas and Fas-ligand expression during melanoma progression. Br. J. Dermatol. 143:307-312.
43. Tollefson, A., T. W. Hermiston, D. L. Lichtenstein, C. F. Colle, R. A. Tripp, T. Dimitrov, K. Toth, C. E. Wells, P. C. Doherty, and W. S. M. Wold. 1998. Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392:726-730.
44. Ungefroren, H., M. Voss, M. Jansen, C. Roeder, D. Henne-Bruns, B. Kremer, and H. Kalthoff. 1998. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 58:1741-1749.
45. Ungefroren, H., M. L. Kruse, A. Trauzold, S. Roeschmann, C. Roeder, A. Arlt, D. Henne-Bruns, and H. Kalthoff. 2001. FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95mediated apoptosis. J. Cell Sci. 114:2735-2746.
46. Walma, T., C. Spronk, M. Tessari, J. Aelen, J. Schepens, W. Hendriks, and G. W. Vuister. 2002. Structure, dynamics and binding characteristics of the second PDZ domain of PTP-BL. J. Mol. Biol. 316:1101-1110.
47. Yanagisawa, J., M. Takahashi, H. Kanki, H. Yano-Yanagisawa, T. Tazunoki, E. Sawa, T. Nishitoba, M. Kamishohara, E. Kobayashi, S. Kataoka, and T. Sato. 1997. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272:8539-8545.